Trillium Therapeutics


Updates from The Motley Fool

Latest updates on Trillium Therapeutics from Fool.com.

There is no available coverage of Trillium Therapeutics at this time.



Stock Performance

View Interactive TRIL Charts
Sponsored by

Key Data Points

Primary metrics and data points about Trillium Therapeutics.
Current Price: $6.15
Prev Close: $6.25
Open: $6.30
Bid: $6.05
Ask: $7.50
Day's Range: $5.85 - $6.35
52wk Range: $4.50 - $17.70
Volume: 84,905
Avg Vol 92,523
Market Cap: $48M
P/E (ttm): -2.07
EPS (ttm): ($3.02)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Trillium Therapeutics.
CAPS Rating 5 out of 5
 
18 Outperform
0 Underperform
CAPS All Stars
 
11 Outperform
0 Underperform

How do you think Trillium Therapeutics will perform against the market?



You pick for Trillium Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Trillium Therapeutics.

Trillium Therapeutics

  • Exchange: NASDAQ